Literature DB >> 24004231

Sleeping and resting respiratory rates in dogs with subclinical heart disease.

Dan G Ohad1, Mark Rishniw, Ingrid Ljungvall, Francesco Porciello, Jens Häggström.   

Abstract

OBJECTIVE: To characterize sleeping respiratory rates (SRRs) and resting respiratory rates (RRRs), collected in the home environment, of dogs with subclinical heart disease that could result in left-sided congestive heart failure.
DESIGN: Prospective cross-sectional study. ANIMALS: 190 adult dogs with subclinical left-sided heart disease. PROCEDURES: Most dogs had mitral valve disease or dilated cardiomyopathy of various severities. Clients collected ten 1-minute SRRs or RRRs during a period ranging from 1 week to 6 months. Clinicians provided echocardiographic and medical data on each patient.
RESULTS: The within-dog mean SRR (SRRmean; 16 breaths/min) was significantly lower than the within-dog mean RRR (RRRmean; 21 breaths/min). Seven dogs had SRRmean and 33 dogs had RRRmean > 25 breaths/min; 1 dog had SRRmean and 12 dogs had RRRmean > 30 breaths/min; these dogs mostly had a left atrial (LA)-to-aortic ratio > 1.8. Dogs with moderate LA enlargement had a significantly higher SRRmean than did other dogs. However, median SRRmean for each of 4 levels of LA enlargement was < 20 breaths/min; median RRRmean for each of 4 levels of LA enlargement was < 25 breaths/min. Both within-dog SRR and RRR remained stable for 10 consecutive measurements. Treatment with cardiac medications or presence of pulmonary hypertension was not associated with SRRmean or RRRmean. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that dogs with confirmed subclinical left-sided heart disease of various severities generally had SRRmean < 25 breaths/min, which was infrequently exceeded at any time, and that SRR and RRR remained stable, regardless of individual within-dog SRRmean or RRRmean.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24004231     DOI: 10.2460/javma.243.6.839

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Clinical severity score system in dogs with degenerative mitral valve disease.

Authors:  J López-Alvarez; J Elliott; D Pfeiffer; Y-M Chang; M Mattin; W Moonarmart; M J Hezzell; A Boswood
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

2.  Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.

Authors:  M Borgarelli; J Abbott; L Braz-Ruivo; D Chiavegato; S Crosara; K Lamb; I Ljungvall; M Poggi; R A Santilli; J Haggstrom
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

3.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

4.  Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.

Authors:  Adrian Boswood; Sonya G Gordon; Jens Häggström; Martin Vanselow; Gerhard Wess; Rebecca L Stepien; Mark A Oyama; Bruce W Keene; John Bonagura; Kristin A MacDonald; Mark Patteson; Sarah Smith; Philip R Fox; Karen Sanderson; Richard Woolley; Viktor Szatmári; Pierre Menaut; Whitney M Church; M Lynne O'Sullivan; Jean-Philippe Jaudon; Jan-Gerd Kresken; John Rush; Kirstie A Barrett; Steven L Rosenthal; Ashley B Saunders; Ingrid Ljungvall; Michael Deinert; Eric Bomassi; Amara H Estrada; Maria J Fernandez Del Palacio; N Sydney Moise; Jonathan A Abbott; Yoko Fujii; Alan Spier; Michael W Luethy; Roberto A Santilli; Masami Uechi; Anna Tidholm; Christoph Schummer; Philip Watson
Journal:  J Vet Intern Med       Date:  2020-03-22       Impact factor: 3.333

5.  Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary-care veterinary practices in the United Kingdom.

Authors:  M J Mattin; A Boswood; D B Church; D C Brodbelt
Journal:  J Vet Intern Med       Date:  2018-10-24       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.